Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

TXG

10x Genomics (TXG)

10x Genomics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TXG
DataHoraFonteTítuloCódigoCompanhia
31/05/202417:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
29/05/202417:05PR Newswire (US)10x Genomics Launches 5,000-Plex Gene Panel for XeniumNASDAQ:TXG10x Genomics Inc
22/05/202417:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
02/05/202417:05PR Newswire (US)10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
30/04/202417:05PR Newswire (US)10x Genomics Reports First Quarter 2024 Financial ResultsNASDAQ:TXG10x Genomics Inc
10/04/202417:05PR Newswire (US)10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:TXG10x Genomics Inc
26/03/202410:00PR Newswire (US)10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayNASDAQ:TXG10x Genomics Inc
21/03/202417:05PR Newswire (US)10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelNASDAQ:TXG10x Genomics Inc
13/03/202417:05PR Newswire (US)10x Genomics Begins Commercial Shipments of Chromium GEM-X ProductsNASDAQ:TXG10x Genomics Inc
20/02/202418:05PR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
15/02/202419:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
15/02/202419:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
15/02/202418:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
15/02/202418:05PR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
07/02/202418:05PR Newswire (US)10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyNASDAQ:TXG10x Genomics Inc
05/02/202418:05PR Newswire (US)10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General MeetingNASDAQ:TXG10x Genomics Inc
24/01/202418:05PR Newswire (US)10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024NASDAQ:TXG10x Genomics Inc
08/01/202411:00PR Newswire (US)10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:TXG10x Genomics Inc
21/12/202318:05PR Newswire (US)10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
20/12/202318:05PR Newswire (US)10x Genomics Launches Xenium Catalyst NetworkNASDAQ:TXG10x Genomics Inc
19/12/202311:00PR Newswire (US)Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor InvasivenessNASDAQ:TXG10x Genomics Inc
13/12/202318:26PR Newswire (US)High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking PreprintNASDAQ:TXG10x Genomics Inc
07/12/202311:00PR Newswire (US)10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human BrainNASDAQ:TXG10x Genomics Inc
17/11/202319:22PR Newswire (US)10x Genomics Wins Another Patent Infringement Case Against NanoString TechnologiesNASDAQ:TXG10x Genomics Inc
06/11/202318:05PR Newswire (US)OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC StudyNASDAQ:TXG10x Genomics Inc
02/11/202317:05PR Newswire (US)10x Genomics Reports Third Quarter 2023 Financial ResultsNASDAQ:TXG10x Genomics Inc
01/11/202317:05PR Newswire (US)10x Genomics to Present at the Stephens 25th Annual ConferenceNASDAQ:TXG10x Genomics Inc
26/10/202317:05PR Newswire (US)Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain TumorsNASDAQ:TXG10x Genomics Inc
11/10/202317:05PR Newswire (US)10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:TXG10x Genomics Inc
10/10/202313:06PR Newswire (US)10x Genomics Comments on Second UPC Preliminary Injunction DecisionNASDAQ:TXG10x Genomics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TXG